Cargando…
Syndecan-1 Expression Is Associated with Tumor Size and EGFR Expression in Colorectal Carcinoma: A Clinicopathological Study of 230 Cases
Background: Syndecan-1 (SDC1) is reported to modulate several key processes of tumorigenesis and has variable expression in many cancers. To date, the cause of altered expression has not been elucidated. In this study, we compared SDC1 expression with various clinicopathological parameters and molec...
Autores principales: | Kim, Su Young, Choi, Eun Ji, Yun, Jeong A, Jung, Eun Sun, Oh, Seung Taek, Kim, Jun Gi, Kang, Won Kyung, Lee, Sung Hak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4293174/ https://www.ncbi.nlm.nih.gov/pubmed/25589885 http://dx.doi.org/10.7150/ijms.10497 |
Ejemplares similares
-
Nuclear Expression of GS28 Protein: A Novel Biomarker that Predicts Prognosis in Colorectal Cancers
por: Lee, Sung Hak, et al.
Publicado: (2017) -
Clinicopathologic Implications of PIWIL2 Expression in Colorectal Cancer
por: Oh, Sun-Ju, et al.
Publicado: (2012) -
High expression of syndecan-4 is related to clinicopathological features and poor prognosis of pancreatic adenocarcinoma
por: Zhu, Yufei, et al.
Publicado: (2022) -
MicroRNA expression profiles and clinicopathological implications in lung adenocarcinoma according to EGFR, KRAS, and ALK status
por: Kim, Hyojin, et al.
Publicado: (2016) -
Analysis of Syndecan-2 Methylation in Bowel Lavage Fluid for the Detection of Colorectal Neoplasm
por: Park, Young Sook, et al.
Publicado: (2018)